Emerging Treatment Approaches and Multidisciplinary Management of Unresectable Stage III Non-Small Cell Lung Cancer - Episode 11
Key Takeaways From the PACIFIC-2 Trial: The Role of Concurrent Immunotherapy With CRT
The discussion explores promising future directions for managing locally advanced disease, focusing on combination immunotherapy approaches and the ongoing trials investigating their efficacy, as well as the potential role of combining chemotherapy (CRT) with immunotherapy in treatment regimens.
Video Player is loading.
Video content above is prompted by the following:
- Briefly discuss the potential role of combination therapy in the consolidation setting. Where may this fit in the treatment paradigm?
Related Content:
